CDR404
CDR404, is our most advanced program for solid tumors. It is a potent and tumor-selective M-gager® targeting MAGE-A4, an intracellular oncogene with expression in several frequent and difficult to treat solid tumors including lung, esophageal, and ovarian cancer.